Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Mar 17;14:1098700. doi: 10.3389/fimmu.2023.1098700

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Yang, Wei, Cheng, Ding, Li, Wang, Yang and Wang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

The expression levels in Pan cancer and LUAD and the survival analysis of BTG2 and SerpinB5. (A) BTG2 expression levels in multiple types of human cancers and adjacent normal tissues across TCGA (*P < 0.05, **P <0.01, ***P < 0.001). (B) SerpinB5 expression levels in multiple types of human cancers and adjacent normal tissues across TCGA. (C, E) The expression level of BTG2 in LUAD and normal lung tissues. BTG2 was more highly expressed in LUAD compared with normal lung tissues. (D, F) The expression level of SerpinB5 in LUAD and normal lung tissues. BTG2 was more highly expressed in LUAD compared with normal lung tissues. (G–H) The relationship between BTG2 and SerpinB5 expression and OS in LUAD patients. (I-J) The relationship between BTG2 and SerpinB5 expression and PFS in LUAD patients. (A) (*P < 0.05, **P <0.01, ***P < 0.001, ****P<0.0001, "-" respect P≥0.05).